Overall, infant immunisation coverage is currently >90% in Australia, but there are pockets of under-immunised children including children from migrant s. This study aimed to examine whether on-time vaccination coverage of diphtheria-tetanus-pertussis...
Human vaccines & immunotherapeutics 2020; 16(8): 1945-50 | Luciana et al.
The recent licensure of two different serogroup B recombinant protein meningococcal vaccines in Brazil emphasizes the importance of a better knowledge of the real burden of serogroup B meningococcal (MenB) disease to establish evidence-based vaccination...
Vaccine 2021; 39(8): 1339-48 | Winokur, Patricia et al.
The number of human influenza A (H7N9) infections has escalated since 2013 with high resultant mortality. We conducted a phase II, randomized, partially-blinded trial to evaluate the safety and immunogenicity of an MF59-adjuvanted inactivated, split virion,...
American Journal of Epidemiology 2021; 190(8): 1504-9 | Andrew M Olney et al.
Since its global emergence in 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused multiple epidemics in the United States. Because medical treatments for the virus are still emerging and a vaccine is not yet available, state...
Ao fazer o registo no serviço "VaccinesXpert", aceito que a GNM Healthcare Consulting France SAS utilize os dados inseridos aquando da minha inscrição com o objetivo de me fornecer um envio de informações semanal relacionadas com os seus serviços, em conformidade com a Política de confidencialidade.
Dispõe de um direito de acesso, retificação e supressão sobre os seus dados, que poderá exercer, enviando o seu pedido a dpo@gnmhealthcare.com. Poderá igualmente exercer o seu direito de oposição, anulando a sua subscrição, a qualquer momento, através de um clique sobre o link "Cancelar a inscrição".